Annual report pursuant to Section 13 and 15(d)

Long-Term Assets

Long-Term Assets
12 Months Ended
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Long-Term Assets

Note 9.  Long-Term Assets


Intangible rights acquired


As of December 31, 2019, intangible rights acquired totaled zero. As of December 31, 2018, intangible rights acquired totaled $0.7 million, which were associated with the Company’s Logical Brokerage acquisition in March 2018. The Company made the decision, effective as of December 31, 2019 not to pursue its RiotX / Logical Brokerage business development plan. See Note 4.


Deposits on equipment


During December 2019, the Company purchased 1,000 next generation Bitmain S17 Pro Antminers from Bitmain for approximately $1.4 million. As of December 31, 2019, the Company has not yet received the miners and recorded the $1.4 million as a deposit on the accompanying consolidated balance sheet.




The Company’s intangible assets with finite lives consist of its patents pertaining to its legacy animal health business, which have been out-licensed. For all periods presented, all of the Company’s identifiable intangible assets were subject to amortization. The carrying amounts related to acquired intangible assets as of December 31, 2019 and 2018 were as follows (in thousands):


    December 31, 2019   December 31, 2018
Patents   $ 1,157     $ 1,119  
Accumulated amortization     (698 )     (612 )
Patents, net     459       507  
Convertible note investment     —         200  
Accrued interest convertible note     —         —    
Convertible note     —         200  
Total   $ 459     $ 707  


The following table represents the total estimated amortization of intangible assets for the five succeeding years and thereafter (in thousands):


For the year ended December 31,   Estimated amortization expense
        2020     $ 86  
        2021       86  
        2022       86  
        2023       86  
        2024 and thereafter       115  
        Total     $ 459  


The Company capitalizes legal costs and filing fees associated with obtaining patents on its new discoveries. Once the patents have been issued, the Company amortizes these costs over the shorter of the legal life of the patent or its estimated economic life using the straight-line method. Amortization expense totaled $86,000 and $62,000 for the years ended December 31, 2019 and 2018, respectively. The Company tests intangible assets with finite lives upon significant changes in the Company’s business environment. The testing resulted in no patent impairment charges during the years ended December 31, 2019 and 2018.